Software Effective Solutions Subsidiary MEDCANA (OTC: SFJW) Announces Successful Launch of Test Greenhouses for Microclimates and Genetics with Colombia Partner Firms

MedCana’s initial focus is on partnering and developing companies in Latin America with an initial focus in Colombia and partnerships with laboratories, research facilities, and hospitals throughout the world.

MedCana aims to build our Partner companies into one of the most advanced CBD production and processing organization globally

Medcana – Nature’s Bio Lab

Pharmaceutical Grade Cannabidiol

Medcana, a global infrastructure and holding company in the cannabis industry

Medcana’s goal is to be the world’s premier resource for pharmaceutical cannabis products

New Orleans, Louisiana, Oct. 27, 2022 (GLOBE NEWSWIRE) — Software Effective Solutions Corporation (OTC: SFWJ) (“The Company”, “SFWJ”) subsidiary Medcana is pleased to announce the successful launch of test greenhouses for microclimates and genetics with five partner firms in Colombia, South America. With significantly better economics than the US and Canada, a central location for exportation to major markets, and prime cultivation characteristics, Colombia is believed by many to have significant cultivation advantages over other regions around the world. 

According to Arcview Market Research, the cost to cultivate cannabis in Colombia is 60X less expensive than in Canada and 30X less than in the U.S.

José Gabriel Diaz, The Company’s CEO, states, “We have begun simultaneous testing in all five partner companies. The goal is to test microclimate, genetics, local pests, and any other factors that may affect the final design and selection of genetics. The plan is to have our partners run tests with desired strands and analyze initial results.”

“As well, the greenhouses are a very small fraction of the planned builds but allow us to test conditions and begin micro-testing genetics. The plan is to run one 90-day cycle and make sure the test parameters yield the expected results.”

Medcana partners will also be running tests in native soil for near-term open-air cultivation possibilities for the Company. For now, the greenhouses give Medcana and partners a controlled environment to ensure native soil results are accurate.

Software Effective Solutions/MedCana is a global infrastructure and holding company in the cannabis industry. The recent acquisition of a software company expanded the offering to provide traceability from plant to product. MedCana’s initial focus is on developing clients and companies in Latin America, with an initial focus on Colombia and partnerships with laboratories, research facilities, and hospitals throughout the world

“In order to build something right and well, we must go slow, analyze, and test all variables.   We have done a phenomenal job with the initial analysis for infrastructure, with geological, hydrological, and environmental factors.  Now we want to test further. All things matter, wind currents, small changes in humidity, soil, pests, we want to make sure all is analyzed and tested,” adds Diaz.

MedCana aims to build its Partner companies into one of the most advanced Cannabinoid production and processing organizations globally

SAFE HARBOR STATEMENT

This press release contains forward-looking statements that can be identified by terminology such as “believes,” “expects,” “potential,” “plans,” “suggests,” “may,” “should,” “could,” “intends,” or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company’s control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Signed.
/s/ Jose Gabriel Diaz, CEO
www.medcana.net  
info@medcana.co

FOR MORE INFORMATION
PLEASE CONTACT:
Chris Greta
512-587-5175
chris@chrisgreta.com

www.medcana.net  
info@medcana.co

Attachments

Staff

Recent Posts

72 Million American Women Have Skipped or Delayed Vital Screenings

New Survey Reveals Women Struggle to Prioritize Their HealthMARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #HGWHI--Millions of women in…

2 hours ago

New-Generation Slow-Dissolving Chlorine Tablets Provide Superior Pool Protection

Introducing 3Chlorine New-Generation Chlorine Tablets to Provide Unparalleled Pool Maintenance and SanitationRANCHO MIRAGE, CA /…

2 hours ago

Invitation to Cosmo’s Half-Year 2024 Webcast on 24 July 2024

Dublin, Ireland--(Newsfile Corp. - July 9, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43)…

6 hours ago

Rosen Law Firm Urges SeaStar Medical Holding Corporation (ICU, ICUCW) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder…

8 hours ago

Best Rated San Antonio Plastic Surgeons for 2024 (Q1) Research Report Released by Doctor Marketing, MD

The Review Growth Index™ (RGI™) by Doctor Marketing, MD™ releases the researched list of Top…

8 hours ago